Bifogade filer
Coala Q1 2022 ENG FINAL
Kurs
-6,97%
Prenumeration
Kalender
| Est. tid* | ||
| 2024-03-26 | - | Bokslutskommuniké 2023 |
| 2023-12-22 | - | Extra Bolagsstämma 2023 |
| 2023-11-23 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-11 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-17 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-31 | - | Bokslutskommuniké 2022 |
| 2023-01-26 | - | Extra Bolagsstämma 2022 |
| 2022-11-16 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-31 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2022-05-30 | - | Årsstämma |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-04 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-12-14 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2021-11-04 | - | Split COALA 50:1 |
| 2021-10-29 | - | Extra Bolagsstämma 2021 |
| 2021-08-10 | - | Extra Bolagsstämma 2021 |
| 2021-06-24 | - | Kvartalsrapport 2021-Q3 |
| 2021-03-25 | - | Kvartalsrapport 2021-Q2 |
| 2020-12-23 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2020-12-22 | - | Årsstämma |
| 2020-12-22 | - | Kvartalsrapport 2021-Q1 |
| 2020-10-22 | - | Bokslutskommuniké 2020 |
| 2020-06-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-03-26 | - | Kvartalsrapport 2020-Q2 |
| 2019-12-20 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2019-12-19 | - | Årsstämma |
| 2019-12-12 | - | Kvartalsrapport 2020-Q1 |
| 2019-10-30 | - | Extra Bolagsstämma 2019 |
| 2019-10-10 | - | Bokslutskommuniké 2019 |
| 2019-06-26 | - | Kvartalsrapport 2019-Q3 |
| 2019-03-26 | - | Kvartalsrapport 2019-Q2 |
| 2018-12-21 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2018-12-20 | - | Årsstämma |
| 2018-12-20 | - | Kvartalsrapport 2019-Q1 |
| 2018-10-11 | - | Bokslutskommuniké 2018 |
| 2018-03-27 | - | Kvartalsrapport 2018-Q2 |
| 2017-12-22 | - | X-dag ordinarie utdelning COALA 0.30 SEK |
| 2017-12-21 | - | Årsstämma |
| 2017-10-12 | - | Bokslutskommuniké 2017 |
| 2017-07-21 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-21 | - | Kvartalsrapport 2017-Q3 |
| 2017-03-27 | - | Kvartalsrapport 2017-Q2 |
| 2016-12-22 | - | X-dag ordinarie utdelning COALA 0.25 SEK |
| 2016-12-21 | - | Årsstämma |
| 2016-12-21 | - | Kvartalsrapport 2017-Q1 |
| 2016-10-19 | - | Bokslutskommuniké 2016 |
| 2016-06-23 | - | Kvartalsrapport 2016-Q3 |
| 2016-03-24 | - | Kvartalsrapport 2016-Q2 |
| 2015-12-18 | - | X-dag ordinarie utdelning COALA 0.25 SEK |
| 2015-12-17 | - | Årsstämma |
| 2015-12-17 | - | Kvartalsrapport 2016-Q1 |
| 2015-10-22 | - | Bokslutskommuniké 2015 |
| 2015-06-23 | - | Kvartalsrapport 2015-Q3 |
| 2015-03-26 | - | Kvartalsrapport 2015-Q2 |
| 2014-12-19 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2014-12-18 | - | Årsstämma |
| 2014-12-18 | - | Kvartalsrapport 2015-Q1 |
| 2014-10-23 | - | Bokslutskommuniké 2014 |
| 2014-06-26 | - | Kvartalsrapport 2014-Q3 |
| 2014-04-02 | - | Kvartalsrapport 2014-Q2 |
| 2014-01-17 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2014-01-16 | - | Årsstämma |
| 2014-01-15 | - | Kvartalsrapport 2014-Q1 |
| 2013-10-31 | - | Analytiker möte 2013 |
| 2013-10-31 | - | Bokslutskommuniké 2013 |
| 2013-06-27 | - | Kvartalsrapport 2013-Q3 |
| 2013-06-05 | - | Split COALA 200:1 |
| 2013-03-27 | - | Extra Bolagsstämma 2013 |
| 2013-03-25 | - | Kvartalsrapport 2013-Q2 |
| 2013-01-18 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2013-01-17 | - | Årsstämma |
| 2013-01-16 | - | Kvartalsrapport 2013-Q1 |
| 2012-10-24 | - | Bokslutskommuniké 2012 |
| 2012-06-27 | - | Kvartalsrapport 2012-Q3 |
| 2012-03-30 | - | Kvartalsrapport 2012-Q2 |
| 2012-01-20 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2012-01-19 | - | Årsstämma |
| 2012-01-18 | - | Kvartalsrapport 2012-Q1 |
| 2011-10-27 | - | Bokslutskommuniké 2011 |
| 2011-06-30 | - | Kvartalsrapport 2011-Q3 |
| 2011-04-06 | - | Kvartalsrapport 2011-Q2 |
| 2011-01-21 | - | X-dag ordinarie utdelning COALA 0.00 SEK |
| 2011-01-20 | - | Årsstämma |
| 2011-01-19 | - | Kvartalsrapport 2011-Q1 |
| 2010-10-22 | - | Kvartalsrapport 2010-Q3 |
| 2010-10-21 | - | Bokslutskommuniké 2010 |
| 2010-06-23 | - | Kvartalsrapport 2010-Q2 |
| 2010-03-26 | - | Kvartalsrapport 2010-Q1 |
| 2010-01-13 | - | Kvartalsrapport 2009-Q1 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-06-17 | - | Kvartalsrapport 2009-Q2 |
| 2009-01-28 | - | Årsstämma |
| 2006-03-01 | - | Split COALA 1:2 |
| 2005-05-04 | - | Split COALA 1:2 |
Beskrivning
| Land | Sverige |
|---|---|
| Sektor | Hälsovård |
| Industri | Medicinteknik |
First quarter 2022
- Net sales increased to SEK 1.8 M (1.3).
- EBITDA totaled SEK -26.9 M (-13.0).
- Operating income totaled SEK -28.0 M (-13.8).
- Profit after tax was SEK -27.8 M (-13.9).
- Earnings per share was SEK -0.8 (-6.8).
- Cash flow from operating activities was SEK -35.4 M (-14.3).
Events in the period
- On February 9, the company announced that a review of the health economics of the Coala Heart Monitor Pro, carried out by the Swedish Dental and Pharmaceutical Benefits Agency, had demonstrated that the device was cost effective.
- On February 23, the company announced its intention to carry out a fully guaranteed rights issue of approximately SEK 150 M.
- In March, Johan Eckerdal started the position as VP R&D.
- On March 14, the company gave an update of the business progress in the US and that it had signed contracts with 10 new clinics during the first quarter.
- On March 14, the Extraordinary General Meeting resolved to authorize the Board to increase the share capital to carry out a new share issue and to introduce an incentive program in the form of options
- On March 15, the company published its Annual Report for 2021.
- On March 17, the board of directors resolved to proceed with a fully guaranteed rights issue of approximately SEK 150 M.
- On March 24, the company published the prospectus related to a fully guaranteed rights issue
Events after the end of the period
- On April 13, the company announced a resolution of a fully guaranteed rights issue of approximately SEK 150 M.
- On April 15, the company announced that it received FDA 510k clearance for remote lung auscultation and enhanced ECG algorithm.
- In April, the company reported that the Coala Heart Monitor had been recommended by the Medical Technology Product Council for introduction into clinical use in Sweden.
- On April 26, the company gave notice to attend the Annual General Meeting on May 30.
Comments from the CEO
After an eventful quarter, we have progressed further in building what will become a profitable business in the US market. Great interest has been shown in Coala Life’s Managed RPM and 10 new clinics connected in the quarter. After the end of the period, the Coala Heart Monitor received an additional FDA 510k clearance for remote lung auscultation and enhanced ECG algorithm. It also gained important recognition from The Swedish Medical Technology Product Council (MTP) which recommended the use of the Coala Heart Monitor in all Swedish regional councils for assessment and diagnostics of patients with suspected atrial fibrillation. During the quarter, we developed our product platform further, intensified the sales focus in the US and prepared the rights issue which was completed after the end of the period and which raised approximately SEK 150 million for Coala Life, before deduction of transaction related costs.
About us
Coala Life is a medical device company founded in Sweden focusing on cloud-based cardiac and pulmonary diagnostics. The company has developed and launched the Coala Heart Monitor - a multi-award winning, FDA-cleared and CE-approved product platform enabling long-term remote monitoring, analysis and algorithm-based diagnostics of heart and auscultation of lungs, remote in real-time. The Coala Heart Monitor is mainly marketed to healthcare providers as an Rx solution for use in patient’s everyday life and home environment. The company's solutions are based on over 10 years of R&D, and are protected by more than 30 patents. The head office is based in Uppsala, Sweden and since 2019, the US office is based in Irvine, California. More than 10,000 patients have used, been diagnosed or are under long-term monitoring with the Coala Heart Monitor. In the Coala Care Portal, there are currently more than 1,700 doctors and nurses connected to more than 500 care providers. For more information see www.coalalife.com
For more information, contact:
Dan Pitulia, CEO Coala Life AB
+46 70 972 08 38, dan.pitulia@coalalife.com
Philip Siberg, Co-founder, Chief Strategy Officer and Head of IR
+46 70 790 67 34, philip.siberg@coalalife.com
Certified Adviser
The company's Certified Adviser is Erik Penser Bank AB.
Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm,
tel: +46 (0) 8-463 80 00
email: certifiedadviser@penser.se
This information is information that Coala Life is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-05-24 07:00 CEST.